Literature DB >> 27503276

Allosteric HIV-1 integrase inhibitors promote aberrant protein multimerization by directly mediating inter-subunit interactions: Structural and thermodynamic modeling studies.

Nanjie Deng1, Ashley Hoyte2, Yara E Mansour3,4, Mosaad S Mohamed4, James R Fuchs3, Alan N Engelman5, Mamuka Kvaratskhelia2, Ronald Levy6.   

Abstract

Allosteric HIV-1 integrase (IN) inhibitors (ALLINIs) bind at the dimer interface of the IN catalytic core domain (CCD), and potently inhibit HIV-1 by promoting aberrant, higher-order IN multimerization. Little is known about the structural organization of the inhibitor-induced IN multimers and important questions regarding how ALLINIs promote aberrant IN multimerization remain to be answered. On the basis of physical chemistry principles and from our analysis of experimental information, we propose that inhibitor-induced multimerization is mediated by ALLINIs directly promoting inter-subunit interactions between the CCD dimer and a C-terminal domain (CTD) of another IN dimer. Guided by this hypothesis, we have built atomic models of inter-subunit interfaces in IN multimers by incorporating information from hydrogen-deuterium exchange (HDX) measurements to drive protein-protein docking. We have also developed a novel free energy simulation method to estimate the effects of ALLINI binding on the association of the CCD and CTD. Using this structural and thermodynamic modeling approach, we show that multimer inter-subunit interface models can account for several experimental observations about ALLINI-induced multimerization, including large differences in the potencies of various ALLINIs, the mechanisms of resistance mutations, and the crucial role of solvent exposed R-groups in the high potency of certain ALLINIs. Our study predicts that CTD residues Tyr226, Trp235 and Lys266 are involved in the aberrant multimer interfaces. The key finding of the study is that it suggests the possibility of ALLINIs facilitating inter-subunit interactions between an external CTD and the CCD-CCD dimer interface.
© 2016 The Protein Society.

Entities:  

Keywords:  HIV-1 integrase; allosteric HIV-1 integrase inhibitor; protein-ligand binding; protein-protein docking

Mesh:

Substances:

Year:  2016        PMID: 27503276      PMCID: PMC5079246          DOI: 10.1002/pro.2997

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  28 in total

1.  Multimode, cooperative mechanism of action of allosteric HIV-1 integrase inhibitors.

Authors:  Jacques J Kessl; Nivedita Jena; Yasuhiro Koh; Humeyra Taskent-Sezgin; Alison Slaughter; Lei Feng; Suresh de Silva; Li Wu; Stuart F J Le Grice; Alan Engelman; James R Fuchs; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2012-03-21       Impact factor: 5.157

2.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes.

Authors:  Richard A Friesner; Robert B Murphy; Matthew P Repasky; Leah L Frye; Jeremy R Greenwood; Thomas A Halgren; Paul C Sanschagrin; Daniel T Mainz
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

3.  Insights into affinity and specificity in the complexes of alpha-lytic protease and its inhibitor proteins: binding free energy from molecular dynamics simulation.

Authors:  Nan-Jie Deng; Piotr Cieplak
Journal:  Phys Chem Chem Phys       Date:  2009-04-02       Impact factor: 3.676

Review 4.  Anatomy of hot spots in protein interfaces.

Authors:  A A Bogan; K S Thorn
Journal:  J Mol Biol       Date:  1998-07-03       Impact factor: 5.469

5.  The A128T resistance mutation reveals aberrant protein multimerization as the primary mechanism of action of allosteric HIV-1 integrase inhibitors.

Authors:  Lei Feng; Amit Sharma; Alison Slaughter; Nivedita Jena; Yasuhiro Koh; Nikolozi Shkriabai; Ross C Larue; Pratiq A Patel; Hiroaki Mitsuya; Jacques J Kessl; Alan Engelman; James R Fuchs; Mamuka Kvaratskhelia
Journal:  J Biol Chem       Date:  2013-04-24       Impact factor: 5.157

6.  Preclinical profile of BI 224436, a novel HIV-1 non-catalytic-site integrase inhibitor.

Authors:  Craig Fenwick; Ma'an Amad; Murray D Bailey; Richard Bethell; Michael Bös; Pierre Bonneau; Michael Cordingley; René Coulombe; Jianmin Duan; Paul Edwards; Lee D Fader; Anne-Marie Faucher; Michel Garneau; Araz Jakalian; Stephen Kawai; Louie Lamorte; Steven LaPlante; Laibin Luo; Steve Mason; Marc-André Poupart; Nathalie Rioux; Patricia Schroeder; Bruno Simoneau; Sonia Tremblay; Youla Tsantrizos; Myriam Witvrouw; Christiane Yoakim
Journal:  Antimicrob Agents Chemother       Date:  2014-03-24       Impact factor: 5.191

7.  Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1.

Authors:  Lee D Fader; Eric Malenfant; Mathieu Parisien; Rebekah Carson; François Bilodeau; Serge Landry; Marc Pesant; Christian Brochu; Sébastien Morin; Catherine Chabot; Ted Halmos; Yves Bousquet; Murray D Bailey; Stephen H Kawai; René Coulombe; Steven LaPlante; Araz Jakalian; Punit K Bhardwaj; Dominik Wernic; Patricia Schroeder; Ma'an Amad; Paul Edwards; Michel Garneau; Jianmin Duan; Michael Cordingley; Richard Bethell; Stephen W Mason; Michael Bös; Pierre Bonneau; Marc-André Poupart; Anne-Marie Faucher; Bruno Simoneau; Craig Fenwick; Christiane Yoakim; Youla Tsantrizos
Journal:  ACS Med Chem Lett       Date:  2014-01-22       Impact factor: 4.345

8.  Retroviral Integrase Structure and DNA Recombination Mechanism.

Authors:  Alan Engelman; Peter Cherepanov
Journal:  Microbiol Spectr       Date:  2014

9.  The Competitive Interplay between Allosteric HIV-1 Integrase Inhibitor BI/D and LEDGF/p75 during the Early Stage of HIV-1 Replication Adversely Affects Inhibitor Potency.

Authors:  Lei Feng; Venkatasubramanian Dharmarajan; Erik Serrao; Ashley Hoyte; Ross C Larue; Alison Slaughter; Amit Sharma; Matthew R Plumb; Jacques J Kessl; James R Fuchs; Frederic D Bushman; Alan N Engelman; Patrick R Griffin; Mamuka Kvaratskhelia
Journal:  ACS Chem Biol       Date:  2016-03-02       Impact factor: 5.100

10.  LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions.

Authors:  Belete Ayele Desimmie; Rik Schrijvers; Jonas Demeulemeester; Doortje Borrenberghs; Caroline Weydert; Wannes Thys; Sofie Vets; Barbara Van Remoortel; Johan Hofkens; Jan De Rijck; Jelle Hendrix; Norbert Bannert; Rik Gijsbers; Frauke Christ; Zeger Debyser
Journal:  Retrovirology       Date:  2013-05-30       Impact factor: 4.602

View more
  20 in total

Review 1.  Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.

Authors:  Alan N Engelman
Journal:  J Biol Chem       Date:  2019-08-29       Impact factor: 5.157

2.  Exploring the Free-Energy Landscape and Thermodynamics of Protein-Protein Association.

Authors:  Celine Tse; Lauren Wickstrom; Mamuka Kvaratskhelia; Emilio Gallicchio; Ronald Levy; Nanjie Deng
Journal:  Biophys J       Date:  2020-08-12       Impact factor: 4.033

3.  HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity.

Authors:  Kaitlin Anstett; Bluma Brenner; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

Review 4.  Cellular and molecular mechanisms of HIV-1 integration targeting.

Authors:  Alan N Engelman; Parmit K Singh
Journal:  Cell Mol Life Sci       Date:  2018-02-07       Impact factor: 9.261

5.  Comparing alchemical and physical pathway methods for computing the absolute binding free energy of charged ligands.

Authors:  Nanjie Deng; Di Cui; Bin W Zhang; Junchao Xia; Jeffrey Cruz; Ronald Levy
Journal:  Phys Chem Chem Phys       Date:  2018-06-27       Impact factor: 3.676

Review 6.  Art and Science of the Cellular Mesoscale.

Authors:  David S Goodsell; Arthur J Olson; Stefano Forli
Journal:  Trends Biochem Sci       Date:  2020-03-21       Impact factor: 13.807

7.  Combining Alchemical Transformation with a Physical Pathway to Accelerate Absolute Binding Free Energy Calculations of Charged Ligands to Enclosed Binding Sites.

Authors:  Jeffrey Cruz; Lauren Wickstrom; Danzhou Yang; Emilio Gallicchio; Nanjie Deng
Journal:  J Chem Theory Comput       Date:  2020-03-09       Impact factor: 6.006

Review 8.  Structure and function of retroviral integrase.

Authors:  Goedele N Maertens; Alan N Engelman; Peter Cherepanov
Journal:  Nat Rev Microbiol       Date:  2021-07-09       Impact factor: 60.633

Review 9.  Avoiding Drug Resistance in HIV Reverse Transcriptase.

Authors:  Maria E Cilento; Karen A Kirby; Stefan G Sarafianos
Journal:  Chem Rev       Date:  2021-01-28       Impact factor: 60.622

10.  Molecular Dynamics Free Energy Simulations Reveal the Mechanism for the Antiviral Resistance of the M66I HIV-1 Capsid Mutation.

Authors:  Qinfang Sun; Ronald M Levy; Karen A Kirby; Zhengqiang Wang; Stefan G Sarafianos; Nanjie Deng
Journal:  Viruses       Date:  2021-05-15       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.